Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001641172-25-005446
Filing Date
2025-04-18
Accepted
2025-04-18 17:05:10
Documents
3
Period of Report
2025-04-18

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 433124
2 proxy_001.jpg GRAPHIC 413200
3 proxy_002.jpg GRAPHIC 372737
  Complete submission text file 0001641172-25-005446.txt   1516827
Mailing Address 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017
Business Address 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 212 949 4319
Lucid Diagnostics Inc. (Filer) CIK: 0001799011 (see all company filings)

EIN.: 825488042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40901 | Film No.: 25850849
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)